SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

2.

Global warming could be driving up women's cancer risk, find researchers

3.

Many Americans unaware of links between HPV and cancers, poll reveals

4.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

5.

Radiation therapy for patients with breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot